“MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)”. 2013. Mediterranean Journal of Hematology and Infectious Diseases 6 (1): e2014009. https://doi.org/10.4084/mjhid.2014.009.